Oral co-administration of α-lipoic acid, quercetin and captopril prevents gallium arsenide toxicity in rats

Environmental Toxicology and Pharmacology

Volumn 28, Issue 1, 2009, Pages 140-146

  Bhatt, Kapil ^a   Flora, S J S ^a  

^a DEFENCE RESEARCH AND DEVELOPMENT ESTABLISHMENT   (India)

Author keywords

Antioxidant supplementation; Gallium arsenide poisoning; Heme synthesis pathway; Oxidative stress; Prevention

Indexed keywords

CAPTOPRIL; GALLIUM ARSENIDE; GLUTATHIONE; GLUTATHIONE DISULFIDE; PORPHOBILINOGEN SYNTHASE; QUERCETIN; THIOBARBITURIC ACID REACTIVE SUBSTANCE; THIOCTIC ACID;

ACUTE TOXICITY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN LEVEL; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; ENZYME INHIBITION; KIDNEY; LIVER LEVEL; MALE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTECTION; RAT;

RATTUS;

EID: 67349188925     PISSN: 13826689     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.etap.2009.03.012     Document Type: Article

References (52)

1. Balcerzak M., Kopacz M., Kosiorek A., Swiecicka E., and Kus S. Spectrophotometric studies of the interaction of noble metals with quercetin and quercetin-5′-sulfonic acid. Anal. Sci. 20 (2004) 1333-1337
2. Berlin A., and Schaller K.H. European standardized method for the determination of delta aminolevulinic acid dehydratase activity in blood. Zeit. Klin. Chem. Klin. Biochem. 12 (1974) 389-390
3. Bhatt K., Mittal M., Kaul R.K., Bhagyawant S., and Flora S.J.S. Beneficial role of zinc and iron co-administration during gallium arsenide exposure in rats. Curr. Trend. Biotechnol. Pharmacol. 2 (2008) 228-236
4. Bustamante J., Lodge J.K., Marcocci L., Tritscheler H.J., Packer L., and Rihn B.H. α-Lipoic acid in liver metabolism and disease. Free Radic. Biol. Med. 24 (1998) 1023-1039
5. Chavez E., Zazueta C., Osornio A., Holguin J.A., and Miranda M.E. Protective behavior of captopril on Hg++ induced toxicity on kidney mitochondria in vivo and in vitro experiments. J. Pharmacol. Exp. Ther. 256 (1991) 385-390
6. Chen Y.C., Lin-Shiau S.Y., and Lin J.K. Involvement of reactive oxygen species and caspase 3 activation in arsenite-induced apoptosis. J. Cell. Physiol. 177 (1998) 324-333
7. Dalton T.P., Shertzer H.G., and Puga A. Regulation of gene expression by reactive oxygen. Annu. Rev. Pharmacol. Toxicol. 39 (1999) 67-101
8. Ellman G.L. Tissue sulfhydryl groups. Arch. Biochem. 82 (1959) 70-77
9. Ferrali M., Signorini C., Ciccoli L., Bambagioni S., Rossi V., Pompella A., and Comporti M. Protection of erythrocytes against oxidative damage and autologous immunoglobulin G (IgG) binding by iron chelator fluor-benzoil-pyridoxal hydrazone. Biochem. Pharmacol. 59 (2000) 1365-1373
10. Flora S.J.S. Arsenic induced oxidative stress and its reversibility following combined administration of N-acetyl cysteine and meso 2,3-dimercaptosuccinic acid in rats. Clin. Exp. Pharmacol. Physiol. 26 (1999) 865-869
11. Flora S.J.S. Possible health hazards associated with the use of toxic metals in semiconductor industries. J. Occup. Health 42 (2000) 105-110
12. Flora S.J.S. Nutritional components modify metal absorption, toxic response and chelation therapy. J. Nutri. Environ. Med. 12 (2002) 53-67
13. Flora S.J.S., and Das Gupta S. Effect of single gallium arsenide exposure on some biochemical variables in porphyrin metabolism in rats. J. Appl. Toxicol. 12 (1992) 333-334
14. Flora S.J.S., Kumar P., Kannan G.M., and Rai G.P. Acute oral gallium arsenide exposure and changes in certain hematological, hepatic, renal and immunological indices at different time interval in male wistar rats. Toxicol. Lett. 94 (1998) 103-113
15. Flora S.J.S., Dubey R., Kannan G.M., Chauhan R.S., Pant B.P., and Jaiswal D.K. Meso 2,3-dimercaptosuccinic acid (DMSA) and monoisoamyl DMSA effect on gallium arsenide induced pathological liver injury in rats. Toxicol. Lett. 132 (2002) 9-17
16. Flora S.J.S., Mehta A., Rao P.V.L., Kannan G.M., Bhaskar A.S.B., Dube S.N., and Pant B.P. Therapeutic potential of monoisoamyl and monomethyl esters of meso 2,3-dimercaptosuccinic acid in gallium arsenide intoxicated rats. Toxicology 195 (2004) 127-146
17. Flora S.J.S., Bhadauria S., Kannan G.M., and Singh N. Arsenic induced oxidative stress and role of antioxidant supplementation during chelation: a review. J. Environ. Biol. 28 (2007) 333-347
18. Flora S.J.S., Mittal M., and Mehta A. Heavy metal induced oxidative stress and its possible reversal by chelation therapy. Ind. J. Med. Res. 128 (2009) 501-523
19. Fowler B.A., and Sexton M.J. Gallium and semiconductor compounds. Handbook on the Toxicology of Metals (2007), Academic Press pp. 547-555
20. Gilgun-Sherki Y., Melamed E., and Offen D. Antioxidant treatment in Alzheimer's disease, review article. J. Mol. Neurosci. 21 (2003) 1-11
21. Goering P.L., Maronpot R.R., and Fowler B.A. Effect of intratracheal gallium arsenide administration on δ-aminolevulinic acid dehydratase in rats: relationship to urinary excretion of aminolevulinic acid. Toxicol. Appl. Pharmacol. 92 (1987) 179-193
22. Hissin P.J., and Hilf R. A fluorometric method for the determination of oxidized and reduced glutathione in tissue. Anal. Biochem. 74 (1974) 214-226
23. Jollow D.J., Mitchell J.R., Zampaglione Y., and Gillette J.R. Bromobenzene induced liver necrosis, protective role of glutathione and evidence for 3,4-bromobenzene oxide as the toxic metabolite. Pharmacology 11 (1974) 151-169
24. Kakkar P., Das B., and Viswanathan P.N. A modified spectrophotometric assay of superoxide dismutase. Ind. J. Biochem. Biophys. 21 (1984) 130-132
25. Kalia K., Narula G., Kannan G.M., and Flora S.J.S. Effects of combined administration of captopril and DMSA on arsenite induced oxidative stress and blood and tissue arsenic concentration in rats. Comp. Biochem. Physiol. Part C: Pharmacol. Toxicol. 144 (2007) 372-379
26. Kokilavani V., Devi M.A., and Sivarajan K. Combined efficacies of dl α-lipoic acid and meso 2,3-dimercaptosuccinic acid against arsenic induced toxicity in antioxidant system of rats. Toxicol. Lett. 160 (2005) 1-7
27. Lee M.Y., Bae O.K., Chung S.M., Kang K.T., Lee J.Y., and Chung J.H. Enhancement of platelet aggregation and thrombus formation by arsenic in drinking water: a contributing factor to cardiovascular disease. Toxicol. Appl. Pharmacol. 179 (2002) 83-88
28. Mishra D., and Flora S.J.S. Quercetin administration during chelation therapy protects arsenic-induced oxidative stress in mice. Biol. Trace Elem. Res. 7 (2008) 8064-8069
29. Mishra D., Mehta A., and Flora S.J.S. Reversal of arsenic induced hepatic apoptosis with combined administration DMSA and its analogue in Guinea pigs: role of glutathione and linked enzymes. Chem. Res. Toxicol. 21 (2008) 400-407
30. Molina M.F., Reus I.S., Iglesias I., and Benedi J. Quercetin, a flavonoid antioxidant, prevents and protects against ethanol induced oxidative stress in mouse liver. Biol. Pharm. Bull. 26 (2003) 1398-1402
31. Monteiro H.P., and Winterbourn C.C. The superoxide-dependent transfer of iron from ferritin to transferrin and lactoferrin. Biochem. J. 256 (1988) 923-928
32. Nakagawa K., Uneno A., and Nishikawa Y. Interaction between carnosine and captopril on free radical scavenging activity and angiotensine converting enzyme activity in vitro. Yakugaku Zasshi 126 (2006) 37-42
33. Navarro A., Sanchez Del Pino M.J., Gomez C., Peralta J.L., and Boveris A. Behavioral dysfunction, brain oxidative stress, and impaired mitochondrial electron transfer in ageing mice. Am. J. Regul. Comp. Physiol. 282 (2002) R985-R992
34. Nijveldt R.J., van Nood E., van Hoorn D.E.C., Boelens P.G., van Norren K., and van Leeuwen P.A.M. Flavonoids: a review of probable mechanisms of action and potential applications. Am. J. Clin. Nutr. 74 (2001) 418-425
35. Ohkawa H., Ohishi N., and Yagi K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal. Biochem. 95 (1979) 351-358
36. Packer L., Kraemer K., and Rimbach G. Molecular aspects of lipoic acid in the prevention of diabetes complications. Nutrition 17 (2001) 888-895
37. Pande M., and Flora S.J.S. Lead-induced oxidative damage and its response to combined administration of alpha-lipoic acid and succimers in rats. Toxicology 177 (2002) 187-196
38. Ramos A.M., and Aller P. Quercetin decreases intracellular GSH content and potentiates the apoptotic action of the antileukemic drug arsenic trioxide in human leukemia cell lines. Biochem. Pharmacol. 75 (2008) 1912-1923
39. Samuel S., Subathra M., Devi M.A., and Panneerselvam C. Arsenic intoxication-induced reduction of glutathione level and of the activity of related enzymes in rat brain regions: reversal by dl-α-lipoic acid. Arch. Toxicol. 79 (2005) 140-146
40. 3) in the treatment of acute promyelocytic leukemia (APL). II. Clinical efficacy and pharmacokinetics in relapsed patients. Blood 89 (1997) 3354-3360
41. Sikorski E.E., Burns L.A., Stern M.L., Luster M.I., and Munson A.E. Splenic cell targets in gallium arsenide-induced suppression of the primary antibody response. Toxicol. Appl. Pharmacol. 110 (1991) 129-142
42. Simbula G., Columbano A., Ledda-Columbano G.M., Sanna L., Deidda M., Diana A., and Pibiri M. Increased ROS generation and p53 activation in α-lipoic acid-induced apoptosis of hepatoma cells. Apoptosis 12 (2007) 113-123
43. Sinha A.K. Colorimetric assay of catalase. Anal. Biochem. 47 (1972) 389-394
44. Sivaprasad R., Nagaraj M., and Varalakshmi P. Combined efficacies of lipoic acid and 2,3-dimercaptosuccinic acid against lead induced lipid peroxidation in rat liver. J. Nutr. Biochem. 15 (2004) 18-23
45. Socci D.J., Bjugstad K.B., Jones H.C., Pattisapu J.V., and Arendash G.W. Evidence that oxidative stress is associated with the pathophysiology of inherited hydrocephalus in the H-Tx rat model. Exp. Neurol. 155 (1999) 109-117
46. Sun Y., Wu C.L., Bhatt K., Guidry M., and Feng D. Scissors-mode vibrations and the emergence of SU (3) symmetry from the projected deformed mean field. Phys. Rev. Lett. 80 (1998) 672-675
47. Tzakos A.G., Naqvi N., Comporozos K., Pierattelli R., Theodorou V., Husainb A., and Gerothanassis L.P. The molecular basis for the selection of captopril cis and trans conformations by angiotensin I converting enzyme. Bioorg. Med. Chem. Lett. 16 (2006) 5084-5087
48. Valko M., Rhodes C.J., Moncol J., Izakovic M., and Mazur M. Free radicals, metals and antioxidants in oxidative stress-induced cancer. Chem. Biol. Int. 160 (2006) 1-40
49. Webb D.R., Wilson S.E., and Carter D.E. Comparative pulmonary toxicity of gallium arsenide, gallium (III) oxide or arsenic (III) oxide intratracheally instilled into rats. Toxicol. Appl. Pharmacol. 82 (1986) 405-416
50. Wojakowski W., Gminski J., Siemianowicz K., Goss M., and Machalski M. The influence of angiotensin converting enzyme inhibitors on lipid peroxidation in sera and aorta of rabbits in diet-induced hypercholesterolemia. Int. J. Mol. Med. 5 (2000) 591-594
51. Yoshizumi M., Tsuchiya K., Suzaki Y., Kirima K., Kyaw M., Moon J.H., Terao J., and Tamaki T. Quercetin glucuronide prevents VSMC hypertrophy by angiotensin II via the inhibition of JNK and AP-1 signaling pathway. Biochem. Biophys. Res. Commun. 293 (2000) 1458-1465
52. Zhang J.Z., Gao L., Widness M., Xi X., and Kern T.S. Captopril inhibits glucose accumulation in retinal cells in diabetes. Invest. Opthalmol. Visual Sci. 44 (2003) 4001-4005